I-Ibrutinib Intermediate CAS 330792-70-6 Purity >98.0% (HPLC)
Igama Lekhemikhali | 5-Amino-3-(4-Phenoxyphenyl)-1H-Pyrazole-4-Carbonitrile |
Omqondofana | Ibrutinib Intermediate N-3;3-Amino-5-(4-Phenoxyphenyl)pyrazole-4-Carbonitrile;3-Amino-4-Cyano-5-(4-Phenoxyphenyl)pyrazole;5-Amino-3-(4-Phenoxyphenyl)-1H-Pyrazole-4-Carbonitrile |
Inombolo ye-CAS | 330792-70-6 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C16H12N4O |
Isisindo samangqamuzana | 276.29 |
Ukuminyana | 1.37±0.10 g/cm3 |
I-COA ne-MSDS | Iyatholakala |
Umsuka | Shanghai, China |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | I-Off-White to Light Yellow Powder |
Ukuhlanzeka / Indlela Yokuhlaziya | >98.0% (HPLC) |
Ukulahlekelwa Ekumisweni | <1.00% |
Izinsalela Ekushiseni | <0.50% |
Ukungcola Okuphelele | <2.00% |
Izinsimbi Ezisindayo (njenge-Pb) | <20ppm |
1 H NMR Spectrum | Ihambisana Nesakhiwo |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Ibrutinib emaphakathi (CAS: 936563-96-1) |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.
I-5-Amino-3- (4-Phenoxyphenyl)-1H-Pyrazole-4-Carbonitrile (CAS: 330792-70-6) iphakathi kwe-Ibrutinib (CAS: 936563-96-1).I-Ibrutinib ibonisa umthelela wokuvimbela onamandla nongenakuhlehliswa kanye nokukhetha komsebenzi we-enzyme ye-Btk.Kulayini weseli we-DOHH2 owenziwe wasebenza we-BCR, i-Ibrutinib ivimbela i-autophosphorylation ye-Btk, i-phosphorylation ye-Btk's physiological substrate PLCγ, kanye ne-phosphorylation ye-downstream kinase eyengeziwe, i-ERK ne-IC50 ye-11 nM, 29 nM, kanye no-13 nM ngokulandelanayo.I-Ibrutinib ibonisa ukungeniswa okubalulekile okuncike kumthamo kanye nesikhathi esincike ku-cytotoxicity kumaseli we-lymphocytic leukemia (CLL) engapheli.Ngaphezu kwalokho, i-Ibrutinib idala ukufa kweseli kuye ngokuthi i-caspase pathway isebenze futhi iphikisana nekhono lamaseli e-CLL ukuze ande ngemva kokusayina kwe-TLR.